Á. Sánchez

ORCID: 0000-0002-8051-2115
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Bladder and Urothelial Cancer Treatments
  • Pelvic floor disorders treatments
  • Urinary and Genital Oncology Studies
  • COVID-19 and healthcare impacts
  • COVID-19 Clinical Research Studies
  • Fibroblast Growth Factor Research
  • Urinary Bladder and Prostate Research
  • Renal Transplantation Outcomes and Treatments
  • Organ Donation and Transplantation
  • Non-Invasive Vital Sign Monitoring
  • Cancer Research and Treatments
  • Anesthesia and Sedative Agents
  • Organ Transplantation Techniques and Outcomes
  • Ureteral procedures and complications
  • Hemodynamic Monitoring and Therapy
  • SARS-CoV-2 and COVID-19 Research
  • Anorectal Disease Treatments and Outcomes
  • Minimally Invasive Surgical Techniques
  • Medical research and treatments
  • Nursing care and research
  • Vaccine Coverage and Hesitancy
  • SARS-CoV-2 detection and testing
  • Radiomics and Machine Learning in Medical Imaging
  • Occupational exposure and asthma
  • Stoma care and complications

Hospital Universitario Ramón y Cajal
2019-2023

Universidad de Alcalá
2019-2021

Instituto Ramón y Cajal de Investigación Sanitaria
2019-2021

Hospital Regional Universitario de Málaga
2020-2021

Hôpital Cochin
2021

Children's Hospital
2021

Clínica Santa María
2020

Instituto Cajal
2020

Hospital Universitario Reina Sofía
2016-2019

Instituto Maimónides de Investigación Biomédica de Córdoba
2016-2019

microRNA alterations are involved in bladder cancer tumorigenesis. The aim of the current study was to evaluate potential role miR-100 and miR-138 as prognostic biomarkers Ta/T1 non-muscle-invasive (NMIBC). We assessed a quantitative RT-PCR analysis 50 tumor samples (stage Ta/T1) four healthy adjacent tissues. Western blot used measure protein expression FGFR3 cyclin D3 order know whether these targets can be regulated by miR-138, respectively. statistical included non-parametric tests...

10.1111/apm.12973 article EN Apmis 2019-06-24

The French health authorities extended vaccination against COVID-19 to adolescents in June 2021, during the epidemic resurgence linked delta variant and because of insufficient coverage ensure collective protection. In May we conducted a national online cross-sectional survey 2533 adults France study their attitudes toward vaccines acceptance child/adolescent according targeted age groups (<6 years; 6-11; 12-17) its determinants. We applied multi-model averaged logistic regression for each...

10.1080/21645515.2021.2004838 article EN Human Vaccines & Immunotherapeutics 2021-12-14

Introduction and Objectives: Cancer therapy-related cardiac dysfunction (CTRCD) is a common cause of cancer treatment withdrawal, related to the poor outcomes. The cardiac-specific could recover left ventricular ejection fraction (LVEF). We analyzed clinical profile prognosis patients with CTRCD in real-world scenario. Methods: A retrospective study that include all diagnosed CTRCD, defined as LVEF < 50%. oncologic treatments, predictors mortality recovery, hospital admission, causes...

10.3389/fcvm.2021.721080 article EN cc-by Frontiers in Cardiovascular Medicine 2021-10-29

Seminal vesicles can be affected by tumours originating in other locations. However, primary of the seminal vesicle are extremely rare, with less than 100 cases reported literature. adenocarcinoma is most common type, but there also malign lesions. Diagnosis challenging due to lack early symptoms and well-defined criteria. These usually asymptomatic discovered incidentally during imaging tests or pelvic surgery. Definitive diagnosis requires anatomopathological analysis. Case report...

10.1016/j.eucr.2023.102494 article EN cc-by-nc-nd Urology Case Reports 2023-07-03

Wilms tumor is a rare entity in adulthood, with main presentation the third decade of life. Its diagnosis histological, since there are no radiological tests that differentiate it from other renal tumors. Avidity diagnosis, for which expert pathologist should be consulted at time suspicion, and quickness beginning adjuvant chemotherapy treatment according to SIOP international consensus (ideally before 14 dais), will mark prognosis this pathology.

10.23937/2469-5742/1510060 article EN International Archives of Urology and Complications 2019-09-07

Hernandez, M. J.1; Gomez, L.1; Sanchez, A.2; Soliveres, J.2; Solaz, C.2; De Andrés, J.1 Author Information

10.1097/00003643-201406001-00084 article EN European Journal of Anaesthesiology 2014-06-01
Coming Soon ...